These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2067040)

  • 1. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
    Wu JM
    J Natl Cancer Inst; 1991 Jul; 83(13):963. PubMed ID: 2067040
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
    Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
    Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
    J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
    Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
    J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of biomarkers in epidemiology: the example of bladder cancer.
    Vineis P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():463-7. PubMed ID: 1471198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
    Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
    Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
    Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
    Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
    Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
    J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
    Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke.
    Alberg AJ; Kouzis A; Genkinger JM; Gallicchio L; Burke AE; Hoffman SC; Diener-West M; Helzlsouer KJ; Comstock GW
    Am J Epidemiol; 2007 Mar; 165(6):660-6. PubMed ID: 17204516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
    Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
    Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise.
    Talaska G; Schamer M; Casetta G; Tizzani A; Vineis P
    Cancer Lett; 1994 Aug; 84(1):93-7. PubMed ID: 8076366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
    Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
    Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
    IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
    Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
    Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
    Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9788-91. PubMed ID: 3200858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of bladder cancer.
    Vineis P; Martone T
    Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.